Predicting fatal outcome in the early phase of severe acute pancreatitis by using novel prognostic models

Pancreatology

Volumn 3, Issue 4, 2003, Pages 309-315

  Halonen, Kimmo I ^a,b   Leppäniemi, Ari K ^a   Lundin, Johan E ^b   Puolakkainen, Pauli A ^a   Kemppainen, Esko A ^a   Haapiainen, Reijo K ^a  

^a Meilahti Hospital   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Mortality, pancreatitis; Prognosis, severe acute pancreatitis; Prognostic model; Severe acute pancreatitis

Indexed keywords

CREATININE;

ACCURACY; ACUTE HEMORRHAGIC PANCREATITIS; ACUTE PANCREATITIS; ADOLESCENT; ADULT; AGED; ANALYTIC METHOD; AREA UNDER THE CURVE; ARTICLE; ARTIFICIAL NEURAL NETWORK; ARTIFICIAL VENTILATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DATA ANALYSIS; DIALYSIS; DISEASE COURSE; FATALITY; FEMALE; HEALTH STATUS; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; INTERMETHOD COMPARISON; KIDNEY FAILURE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; MULTIPLE ORGAN FAILURE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PANCREAS NECROSIS; PREDICTION; PREDICTION AND FORECASTING; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; STATISTICAL MODEL; SURVIVAL RATE; VALIDATION PROCESS;

EID: 0042674151     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000071769     Document Type: Article

References (43)

1. Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC: Prognostic signs and role of operative management in acute pancreatitis. Surg Gynecol Obstet 1974;139:69-81.
2. Ranson JH, Rifkind KM, Turner JW: Prognostic signs and nonoperative peritoneal lavage in acute pancreatitis. Surg Gynecol Obstet 1976;143:209-219.
3. Ranson JH: Etiological and prognostic factors in human acute pancreatitis: A review. Am J Gastroenterol 1982;77:633-638.
4. Imrie CW, Benjamin IS, Ferguson JC, McKay AJ, Mackenzie I, O'Neill J, Blumgart LH: A single centre double blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg 1978;65:337-341.
5. Blamey SL, Imrie CW, O'Neill J, Gilmour WH, Carter DC: Prognostic factors in acute pancreatitis. Gut 1984;25:1340-1346.
6. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: A severity of disease classification system. Crit Care Med 1985;13:818-829.
7. Halonen KI, Leppäniemi AK, Puolakkainen PA, Lundin JE, Kemppainen EA, Hietaranta AJ, Haapiainen RJ: Severe acute pancreatitis - prognostic factors in 270 consecutive patients. Pancreas 2000;21:266-271.
8. Haybittle JL, Blamey RW, Elston CW, Johnson J, Doyle PJ, Campbell FC, Nicholson RI, Griffiths K: A prognostic index in primary breast cancer. Br J Cancer 1982;45:361-366.
9. Schuchter L, Schultz DJ, Synnestvedt M, Trock BJ, Guerry D, Elder DE, Elenitsas R, Clark WH, Halpern AC: A prognostic model for predicting 10-year survival in patients with primary melanoma. Ann Intern Med 1996;125:369-375.
10. Lundin M, Lundin J, Burke HB, Toikkanen S, Pylkkänen L, Joensuu H: Artificial neural networks applied to survival prediction in breast cancer. Oncology 1999;57:281-286.
11. Dubowski R, Weller P, Chang R, Gant V: Prediction of outcome in critically ill patients using artificial neural network synthesised by genetic algorithm. Lancet 1996;347:1146-1150.
12. Golub R, Cantu R Jr, Tan M: The prediction of common bile duct stones using a neural network. J Am Coll Surg 1998;187:584-590.
13. Burke HB: Statistical analysis of complex systems in biomedicine; in Fisher D, Lenz HJ (eds): Learning from Data: AI and Statistics V. Berlin, Springer, 1996, vol 112, pp 251-258.
14. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ: Multiple organ dysfuntion score: A reliable descriptor of a complex clinical outcome. Crit Care Med 1995;23:1638-1652.
15. Balthazar EJ, Ranson JH, Naidich DP, Megibow AJ, Caccavale R, Cooper MM: Acute pancreatitis: Prognostic value of CT. Radiology 1985;156:767-772.
16. Balthazar EJ, Freeny PC, van Sonnenberg E: Imaging and intervention in acute pancreatitis. Radiology 1994;193:297-306.
17. 2 in the assessment of the severity of acute pancreatitis. Gut 1987;28:764-771.
18. Büchler M, Malfertheiner P, Schoetensack C, Uhl W, Beger HG: Sensitivity of antiproteases, complement factors, and C-reactive protein in detecting pancreatic necrosis: Results of a prospective clinical study. Int J Pancreatol 1986;1:227-235.
19. Wilson C, Heads A, Shenkin A, Imrie CW: C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis. Br J Surg 1989;76:177-181.
20. Wilson C, Heath DI, Imrie CW: Prediction of outcome in acute pancreatitis: A comparative study of APACHE II, clinical assessment and multiple factor scoring systems. Br J Surg 1990;77:1260-1264.
21. Metz CE: Basic principles of ROC analysis. Semin Nucl Med 1978;8:283-298.
22. Corfield AP, Williamson RN, McMahon MJ, Shearer MG, Cooper MJ, Mayer AD, Dickson AP, Imrie CW: Prediction of severity in acute pancreatitis: Prospective comparison of three prognostic indices. Lancet 1985;ii:403-407.
23. De Bernardinis MD, Violi V, Roncoroni L, Boselli AS, Giunta A, Peracchia A: Discriminant power and information content of Ranson's prognostic signs in acute pancreatitis: A meta-analytic study. Crit Care Med 1999;27:2272-2283.
24. Eachempati SR, Hydo LJ, Barie PS: Severity scoring for prognostication in patients with severe acute pancreatitis: Comparative analysis of the Ranson score and the APACHE III score. Arch Surg 2002;137:730-736.
25. Baxt WG: Complexity, chaos and human physiology: The justification for non-linear neural computational analysis. Cancer Lett 1994;77:85-93.
26. Pofahl WE, Walcak SM, Rhone E, Izenberg SD: Use of artificial neural network to predict length of stay in acute pancreatitis. Am Surg 1998;64:868-872.
27. Ranson JH, Pasternack BS: Statistical methods for quantifying the severity of clinical acute pancreatitis. J Surg Res 1977;22:79-91.
28. Williamson RCN: Early assessment of severity in acute pancreatitis. Gut 1984;25:1331-1339.
29. Fan ST, Choi TK, Lai CS, Wong J: Influence of age on mortality from acute pancreatitis. Br J Surg 1988;75:463-466.
30. Lankisch GL, Burchard-Reckert S, Mechthild P, Lehnick D, Schirren CA, Stöckman F, Köhler H: Etiology and age have only a limited influence on the course of acute pancreatitis. Pancreas 1996;13:344-349.
31. Tenner S, Sica G, Hughes M, Noordhoek E, Feng S, Zinner M, Banks PA: Relationship of necrosis to organ failure in severe acute pancreatitis. Gastroenterology 1997;113:899-903.
32. De Beux AC, Palmer KR, Carter DC: Factors influencing morbidity and mortality in acute pancreatitis: An analysis of 279 cases. Gut 1995;37:121-126.
33. Karimgani I, Porter K, Langevin RE, Banks A: Prognostic factors in sterile pancreatic necrosis. Gastroenterology 1992;103:1636-1640.
34. Uomo G, Visconti M, Manes G, Calise F, Laccetti M, Rabitti PG: Non-surgical treatment of acute necrotizing pancreatitis. Pancreas 1996;12:142-148.
35. De Boux AC, Goldie AS, Ross JA, Carter DC, Fearon KC: Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg 1996;83:349-353.
36. Buter A, Imrie CW, Carter CR, Evans S, McKay CJ: Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis. Br J Surg 2002;89:298-302.
37. Lankisch PG, Pflichthofer D, Lehnick D: Acute pancreatitis: Which patient is most at risk? Pancreas 1999;19:321-324.
38. Bradley EL: A clinically based classification system for acute pancreatitis. Arch Surg 1992;128:586-590.
39. Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A: Reversal of late septic schock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998;26:645-650.
40. Briegel J, Frost H, Haller M, Schelling G, Kilger E, Kuprat G, Hemmer B, Hummel T, Lenhart A, Heyduck M, Stoll C, Peter K: Stress doses of hydrocortisone reverse hyperdynamic septic schock: A prospective, randomised, double-blind, single-center study. Crit Care Med 1999;27:723-732.
41. Eisele B, Lamy M, Thijs LG, Keinecke HO, Schuster HP, Matthias FR, Fourrier F, Heinrichs H, Delvos U: Antithrombin III in patients with severe sepsis: A randomised, placebo-controlled, double-blind, multicenter trial plus a meta-analysis on all randomised, placebo-controlled, douple-blind trials with antithrombin III in severe sepsis. Intensive Care Med 1998;24:663-672.
42. Bernard GR, Vincent JL, Laterre PF, La Rosa SP, Dhainaut JF, Lopez-Rodrigues A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709.
43. Uhl W, Isenmann R, Curti G, Vogel R, Beger HG, Büchler MW: Influence of etiology on the course and outcome of acute pancreatitis. Pancreas 1996;13:335-343.